Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Adjusted Non-GAAP Diluted Net Earnings per Share by Quarter
Adjusted Non-GAAP Diluted Net Earnings per Share ($) ($)
Stryker Adjusted Non-GAAP Diluted Net Earnings per Share: $3.52 in Q3 2026, up 10.3% from a year earlier.
Latest, Q3 2026
3.52
Period ended Sep 30, 2026
Change on a year earlier
+10.3%
3.19 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
15
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Non-GAAP Reconciliations.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up adjusted Non-GAAP Diluted Net Earnings per Share
- Adjusted Non-GAAP Gross Profit ($M)4,266 · Q3 2026
- Adjusted Non-GAAP Operating Income ($M)1,706 · Q3 2026
- Adjusted Non-GAAP Net Earnings ($M)1,357 · Q3 2026
- Adjusted Non-GAAP R&D Expense ($M)417 · Q3 2026
- Adjusted Non-GAAP SG&A Expense ($M)2,143 · Q3 2026
- Operating Income Adjustment — EU Medical Device Regulation (MDR) Costs ($M)6 · Q3 2026
- Operating Income Adjustment — Recall-Related Matters ($M)-4 · Q3 2026
- Operating Income Adjustment — Structural Optimization & Special Charges ($M)153 · Q3 2026
Cite this data
StockData. (2026). Stryker Adjusted Non-GAAP Diluted Net Earnings per Share ($), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-ng-eps
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.